Delivery Order SPE2DB22D2006-SPE2DB25FW2LW
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Bicillin L-A 1,200,000 units in 2mL formulations, with a ceiling value of $1,443.54. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement from the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Bicillin L-A 1,200,000 units (2mL vials) with a ceiling value of $1,443.54. The contract, issued on July 14, 2025, represents a firm fixed-price delivery order with an ultimate completion date of July 15, 2025. This award was competitively procured without set-aside designation and will be performed at AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Bicillin L-A 2,400,000 units in 4ml formulations, with a ceiling value of $2,822.76. This firm fixed-price delivery order represents a non-competitive set-aside award and is scheduled for ultimate completion by September 8, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- This is a $1,072.54 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider. The order is for 1,200,000 units of Bicillin L-A 2ML, a penicillin-based antibiotic medication. The contract has an ultimate completion date of March 13, 2023 and was awarded on March 10, 2023. It is not designated as a set-aside contract. This delivery order is part of a larger $999,999,999 Indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,327.87 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 1,200,000 units of Bicillin L-A, a pharmaceutical product, with a completion date of January 31, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Bicillin L-A 1,200,000 units in 2mL vials, with a ceiling value of $1,443.54. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made without a set-aside designation, indicating the contract was competitively awarded...
- The Defense Logistics Agency awarded a delivery order valued at $227,966.84 to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of Bicillin L-A (penicillin G benzathine) 1,200,000 units in 2 mL formulations. This is a firm fixed-price contract with an ultimate completion date of June 5, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a non-competitive set-aside contract, indicating direct competition through the open...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,887.08 for Bicillin L-A 1,200,000 units in 2mL formulation, effective August 14, 2025, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 1,200,000 units of Bicillin L-A, a penicillin antibiotic. The contract is a firm fixed-price delivery order with a ceiling value of $1,443.54 and a performance period through April 18, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency has awarded a delivery order valued at $1,443.54 to AmerisourceBergen Drug Corp for the supply of Bicillin L-A 1,200,000 units in 2 mL formulations, with a completion date of June 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW2LWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,488.80 to AmerisourceBergen Drug Corp for 1.2 million units of Bicillin L-A 2mL on July 14, 2025, with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Bicillin L-A is a penicillin-based antibiotic commonly used in military and federal healthcare systems for treatment of infections. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. As a major pharmaceutical distributor and critical vendor in the federal medical procurement supply chain, AmerisourceBergen has demonstrated consistent capability to fulfill federal requirements through open competition across multiple therapeutic domains and delivery scales.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 7/14/25 |